The online version of this article (doi:10.1186/1471-2253-14-28) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
ZQ, JJ and MZ participated in the design of the study, performance of the study, interpretation of results and writing. EL, LZ and XX participated in the design of the study, interpretation of results and writing. All authors have read and approved the final manuscript.
Emulsified isoflurane (EIso) is a novel intravenous general anesthetic, which can provide rapid anesthetic induction and recovery. EIso preconditioning could attenuate heart, lung and liver ischemia/reperfusion (I/R) injury. We tested the hypothesis that intravenous pretreatment with EIso would protect kidneys against I/R injury by inhibiting systemic inflammatory responses and improving renal antioxidative ability.
Rats were randomly divided into these six groups: sham, I/R, intralipid, 1, 2 or 4 ml/kg EIso. Rats were subjected to 45 min left renal pedicle occlusion followed by 3 h reperfusion after right nephrectomy. Rat were treated with intravenous 8% EIso with 1, 2 or 4 ml/kg, or 30% intralipid with 2 ml/kg for 30 min before ischemia, respectively. After reperfusion, renal functional parameters, serum mediator concentrations and markers of oxidative stress in kidney tissues were determined, and renal histopathological analysis were performed.
Serum creatinine, blood urea nitrogen, cystatin c, tumor necrosis factor-α, interleukin-6, and interleukin-10 concentrations were significantly increased after renal I/R as compared to the sham group. So was renal tissue MDA content and histological scores, but renal tissue SOD activity was decreased. Additionally, severe morphological damages were observed in these study groups. In contrast, 2 or 4 ml/kg EIso reduced serum creatinine, blood urea nitrogen, cystatin c, tumor necrosis factor-α, and interleukin-6 levels, decreased renal tissue MDA content and histological scores, increased serum interleukin-10 level and tissue SOD activity as compared to the I/R, intralipid and 1 ml/kg EIso groups. Renal morphological damages were alleviated after pretreatment of 2 or 4 ml/kg EIso.
Intravenous EIso produces preconditioning against renal I/R injury in rats, which might be mediated by attenuating inflammation and increasing antioxidation ability.
Fukazawa K, Lee HT: Volatile anesthetics and AKI: risks, mechanisms, and apotential therapeutic window. J Am Soc Nephrol. 2014, http://dx.doi.org/10.1681/ASN.2013111215,
Chiari PC, Pagel PS, Tanaka K, Krolikowski JG, Ludwig LM, Trillo RA, Puri N, Kersten JR, Warltier DC: Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. Anesthesiology. 2004, 101: 1160-1166. 10.1097/00000542-200411000-00016. CrossRefPubMed
Xu WM, Zhang JY, Liu J: Effects of emulsified isoflurane preconditioning on LPS-induced acute lung injury in rats. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013, 44: 554-557. PubMed
Dogan Z, Yuzbasioglu MF, Kurutas EB, Yildiz H, Coskuner I, Senogl N, Oksuz H, Bülbüloglu E: Thiopental improves renal ischemia-reperfusion injury. Renal Fail. 2010, 32: 391-395. 10.3109/08860221003611752. CrossRef
- Intravenous pretreatment with emulsified isoflurane preconditioning protects kidneys against ischemia/reperfusion injury in rats
- BioMed Central
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
Mail Icon II